ANIP icon

ANI Pharmaceuticals
ANIP

Overview Fund Activity

34 hedge funds and large institutions have $4.85M invested in ANI Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
$496K
Puts
$59K
Net Calls
+$437K
Net Calls Change
+$437K

Top Buyers

1
HVC
1
Healthcare Value Capital
New Jersey
$2.55M
2
BIT
2
BlackRock Institutional Trust
California
$1.25M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$535K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$82K
5
Nomura Holdings
5
Nomura Holdings
Japan
$59K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1K 1,009 +1,009 New
LTFS
27
Ladenburg Thalmann Financial Services
Florida
$1K 1,295 +1,295 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– – – –
SC
29
Saiers Capital
New York
– – – –
Wells Fargo
30
Wells Fargo
California
$0 3 +3 New
LFG
31
LifePlan Financial Group
Ohio
$0 5 +5 New
SSG
32
Summit Securities Group
New York
$0 11 +11 New
Toronto Dominion Bank
33
Toronto Dominion Bank
Ontario, Canada
$0 21 +21 New
Deutsche Bank
34
Deutsche Bank
Germany
$0 77 +77 New
WA
35
WFG Advisors
Texas
$0 166 +166 New
DADC
36
D.A. Davidson & Co
Montana
$0 166 +166 New
1
2